Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306663866> ?p ?o ?g. }
- W4306663866 endingPage "1799" @default.
- W4306663866 startingPage "1785" @default.
- W4306663866 abstract "The identification of multiple genetic risk factors for Alzheimer's disease (AD) suggests that many pathways contribute to AD onset and progression. However, the metabolomic and lipidomic profiles in carriers of distinct genetic risk factors are not fully understood. The metabolome can provide a direct image of dysregulated pathways in the brain.We interrogated metabolomic signatures in the AD brain, including carriers of pathogenic variants in APP, PSEN1, and PSEN2 (autosomal dominant AD; ADAD), APOE ɛ4, and TREM2 risk variant carriers, and sporadic AD (sAD).We identified 133 unique and shared metabolites associated with ADAD, TREM2, and sAD. We identified a signature of 16 metabolites significantly altered between groups and associated with AD duration.AD genetic variants show distinct metabolic perturbations. Investigation of these metabolites may provide greater insight into the etiology of AD and its impact on clinical presentation.APP/PSEN1/PSEN2 and TREM2 variant carriers show distinct metabolic changes. A total of 133 metabolites were differentially abundant in AD genetic groups. β-citrylglutamate is differentially abundant in autosomal dominant, TREM2, and sporadic AD. A 16-metabolite profile shows differences between Alzheimer's disease (AD) genetic groups. The identified metabolic profile is associated with duration of disease." @default.
- W4306663866 created "2022-10-18" @default.
- W4306663866 creator A5005057023 @default.
- W4306663866 creator A5010912426 @default.
- W4306663866 creator A5012665887 @default.
- W4306663866 creator A5017017613 @default.
- W4306663866 creator A5018751073 @default.
- W4306663866 creator A5020456913 @default.
- W4306663866 creator A5021030845 @default.
- W4306663866 creator A5025346929 @default.
- W4306663866 creator A5026305547 @default.
- W4306663866 creator A5035514608 @default.
- W4306663866 creator A5037206462 @default.
- W4306663866 creator A5039076767 @default.
- W4306663866 creator A5040490170 @default.
- W4306663866 creator A5041244805 @default.
- W4306663866 creator A5042889556 @default.
- W4306663866 creator A5049771425 @default.
- W4306663866 creator A5051059746 @default.
- W4306663866 creator A5051314083 @default.
- W4306663866 creator A5056894334 @default.
- W4306663866 creator A5063738426 @default.
- W4306663866 creator A5065682914 @default.
- W4306663866 creator A5068373508 @default.
- W4306663866 creator A5071364728 @default.
- W4306663866 creator A5072107333 @default.
- W4306663866 creator A5077760657 @default.
- W4306663866 creator A5088915384 @default.
- W4306663866 creator A5089622493 @default.
- W4306663866 date "2022-10-17" @default.
- W4306663866 modified "2023-10-14" @default.
- W4306663866 title "Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brains" @default.
- W4306663866 cites W1966327575 @default.
- W4306663866 cites W1972340735 @default.
- W4306663866 cites W1977085392 @default.
- W4306663866 cites W1980698168 @default.
- W4306663866 cites W1991952617 @default.
- W4306663866 cites W1999794509 @default.
- W4306663866 cites W2005483591 @default.
- W4306663866 cites W2017173865 @default.
- W4306663866 cites W2039684034 @default.
- W4306663866 cites W2043905483 @default.
- W4306663866 cites W2086102398 @default.
- W4306663866 cites W2107199945 @default.
- W4306663866 cites W2119519240 @default.
- W4306663866 cites W2135771073 @default.
- W4306663866 cites W2136040391 @default.
- W4306663866 cites W2153947402 @default.
- W4306663866 cites W2155158051 @default.
- W4306663866 cites W2155513557 @default.
- W4306663866 cites W2159482845 @default.
- W4306663866 cites W2167540852 @default.
- W4306663866 cites W2167693778 @default.
- W4306663866 cites W2171250577 @default.
- W4306663866 cites W2484758668 @default.
- W4306663866 cites W2587271565 @default.
- W4306663866 cites W2603228471 @default.
- W4306663866 cites W2728134957 @default.
- W4306663866 cites W2766580836 @default.
- W4306663866 cites W2784429314 @default.
- W4306663866 cites W2791435783 @default.
- W4306663866 cites W2793872352 @default.
- W4306663866 cites W2803198382 @default.
- W4306663866 cites W2803664483 @default.
- W4306663866 cites W2805942784 @default.
- W4306663866 cites W2894203109 @default.
- W4306663866 cites W2897805491 @default.
- W4306663866 cites W2903533912 @default.
- W4306663866 cites W2908002252 @default.
- W4306663866 cites W2913321668 @default.
- W4306663866 cites W2914712649 @default.
- W4306663866 cites W2945264725 @default.
- W4306663866 cites W2946974352 @default.
- W4306663866 cites W2966903908 @default.
- W4306663866 cites W2977553419 @default.
- W4306663866 cites W2989336263 @default.
- W4306663866 cites W2996431818 @default.
- W4306663866 cites W2997092212 @default.
- W4306663866 cites W3002293416 @default.
- W4306663866 cites W3007853567 @default.
- W4306663866 cites W3009710006 @default.
- W4306663866 cites W3011658331 @default.
- W4306663866 cites W3084765062 @default.
- W4306663866 cites W3086231708 @default.
- W4306663866 cites W3096828292 @default.
- W4306663866 cites W3119287108 @default.
- W4306663866 cites W3181408683 @default.
- W4306663866 cites W4294216483 @default.
- W4306663866 doi "https://doi.org/10.1002/alz.12800" @default.
- W4306663866 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36251323" @default.
- W4306663866 hasPublicationYear "2022" @default.
- W4306663866 type Work @default.
- W4306663866 citedByCount "4" @default.
- W4306663866 countsByYear W43066638662022 @default.
- W4306663866 countsByYear W43066638662023 @default.
- W4306663866 crossrefType "journal-article" @default.
- W4306663866 hasAuthorship W4306663866A5005057023 @default.
- W4306663866 hasAuthorship W4306663866A5010912426 @default.